South Korea · Delayed Price · Currency is KRW SCL Science Statistics
Total Valuation
SCL Science has a market cap or net worth of KRW 56.87 billion. The enterprise value is 84.71 billion.
| Market Cap | 56.87B |
| Enterprise Value | 84.71B |
Important Dates
The last earnings date was Friday, April 3, 2026.
| Earnings Date | Apr 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SCL Science has 34.01 million shares outstanding. The number of shares has increased by 12.48% in one year.
| Current Share Class | 34.01M |
| Shares Outstanding | 34.01M |
| Shares Change (YoY) | +12.48% |
| Shares Change (QoQ) | +1,158.05% |
| Owned by Insiders (%) | 1.73% |
| Owned by Institutions (%) | n/a |
| Float | 15.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.08 |
| PB Ratio | 2.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 58.76, with an EV/FCF ratio of -59.53.
| EV / Earnings | -26.75 |
| EV / Sales | 3.09 |
| EV / EBITDA | 58.76 |
| EV / EBIT | n/a |
| EV / FCF | -59.53 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 1.10.
| Current Ratio | 1.06 |
| Quick Ratio | 0.83 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | 28.09 |
| Debt / FCF | -20.29 |
| Interest Coverage | -1.05 |
Financial Efficiency
Return on equity (ROE) is -13.25% and return on invested capital (ROIC) is -3.22%.
| Return on Equity (ROE) | -13.25% |
| Return on Assets (ROA) | -2.50% |
| Return on Invested Capital (ROIC) | -3.22% |
| Return on Capital Employed (ROCE) | -4.76% |
| Weighted Average Cost of Capital (WACC) | 6.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.41 |
| Inventory Turnover | 16.07 |
Taxes
| Income Tax | -651.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.50% in the last 52 weeks. The beta is 0.48, so SCL Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -16.50% |
| 50-Day Moving Average | 2,043.58 |
| 200-Day Moving Average | 2,329.87 |
| Relative Strength Index (RSI) | 27.22 |
| Average Volume (20 Days) | 98,257 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SCL Science had revenue of KRW 27.40 billion and -3.17 billion in losses. Loss per share was -92.99.
| Revenue | 27.40B |
| Gross Profit | 5.05B |
| Operating Income | -2.70B |
| Pretax Income | -4.15B |
| Net Income | -3.17B |
| EBITDA | 1.03B |
| EBIT | -2.70B |
| Loss Per Share | -92.99 |
Balance Sheet
The company has 3.68 billion in cash and 28.87 billion in debt, with a net cash position of -25.18 billion or -740.38 per share.
| Cash & Cash Equivalents | 3.68B |
| Total Debt | 28.87B |
| Net Cash | -25.18B |
| Net Cash Per Share | -740.38 |
| Equity (Book Value) | 26.26B |
| Book Value Per Share | 693.92 |
| Working Capital | 1.29B |
Cash Flow
In the last 12 months, operating cash flow was -501.67 million and capital expenditures -921.27 million, giving a free cash flow of -1.42 billion.
| Operating Cash Flow | -501.67M |
| Capital Expenditures | -921.27M |
| Depreciation & Amortization | 3.05B |
| Net Borrowing | 12.47B |
| Free Cash Flow | -1.42B |
| FCF Per Share | -41.83 |
Margins
Gross margin is 18.41%, with operating and profit margins of -9.84% and -11.56%.
| Gross Margin | 18.41% |
| Operating Margin | -9.84% |
| Pretax Margin | -15.13% |
| Profit Margin | -11.56% |
| EBITDA Margin | 3.75% |
| EBIT Margin | -9.84% |
| FCF Margin | n/a |
Dividends & Yields
SCL Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.48% |
| Shareholder Yield | -12.48% |
| Earnings Yield | -5.57% |
| FCF Yield | -2.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 30, 2025. It was a forward split with a ratio of 4.
| Last Split Date | Jun 30, 2025 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
SCL Science has an Altman Z-Score of 0.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.41 |
| Piotroski F-Score | 2 |